[ Price : $8.95]
FDA approves a Celltrion BLA for Vegzelma (bevacizumab-adcd), a biosimilar to Genentechs Avastin (bevacizumab), for treating six c...[ Price : $8.95]
Eisai and Biogen tout the highly significant confirmatory Phase 3 trial results of their investigational Alzheimers drug lecanemab...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Clinical Decision Support Software.[ Price : $8.95]
University of California San Francisco researchers say only one of 15 oncologic drug surrogate analyses conducted by FDA showed a ...[ Price : $8.95]
FDA publishes a guidance on how it will exercise oversight over select software functions in mobile and general purpose computing ...[ Price : $8.95]
FDA announces a collaborative effort with the Veterans Health Administration to speed medical device innovation by developing new ...[ Price : $8.95]
FDA issues Avidity Biosciences a partial clinical hold on new participant enrollment in its Phase 1/2 MARINA clinical trial of AOC...[ Price : $8.95]
Two stakeholders give FDA technical comments on a guidance based on an International Council for Harmonization guideline on drug i...